{"downloaded": true, "htmlmade": false, "full": {"id": "30042390", "source": "MED", "pmid": "30042390", "pmcid": "PMC6057940", "fullTextIdList": {"fullTextId": "PMC6057940"}, "doi": "10.1038/s41467-018-05220-6", "title": "Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.", "authorString": "Cazet AS, Hui MN, Elsworth BL, Wu SZ, Roden D, Chan CL, Skhinas JN, Collot R, Yang J, Harvey K, Johan MZ, Cooper C, Nair R, Herrmann D, McFarland A, Deng N, Ruiz-Borrego M, Rojo F, Trigo JM, Bezares S, Caballero R, Lim E, Timpson P, O'Toole S, Watkins DN, Cox TR, Samuel MS, Mart\u00edn M, Swarbrick A.", "authorList": {"author": [{"fullName": "Cazet AS", "firstName": "Aur\u00e9lie S", "lastName": "Cazet", "initials": "AS", "authorId": {"@type": "ORCID", "#text": "0000-0001-7075-8448"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Hui MN", "firstName": "Mun N", "lastName": "Hui", "initials": "MN", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Chris O' Brien Lifehouse, Camperdown, NSW, 2050, Australia."}, {"affiliation": "Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia."}]}}, {"fullName": "Elsworth BL", "firstName": "Benjamin L", "lastName": "Elsworth", "initials": "BL", "authorId": {"@type": "ORCID", "#text": "0000-0001-7328-4233"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK."}}}, {"fullName": "Wu SZ", "firstName": "Sunny Z", "lastName": "Wu", "initials": "SZ", "authorId": {"@type": "ORCID", "#text": "0000-0002-6153-0449"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Roden D", "firstName": "Daniel", "lastName": "Roden", "initials": "D", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Chan CL", "firstName": "Chia-Ling", "lastName": "Chan", "initials": "CL", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Skhinas JN", "firstName": "Joanna N", "lastName": "Skhinas", "initials": "JN", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Collot R", "firstName": "Rapha\u00ebl", "lastName": "Collot", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Yang J", "firstName": "Jessica", "lastName": "Yang", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Harvey K", "firstName": "Kate", "lastName": "Harvey", "initials": "K", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Johan MZ", "firstName": "M Zahied", "lastName": "Johan", "initials": "MZ", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia."}, {"affiliation": "Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, SA, 5000, Australia."}]}}, {"fullName": "Cooper C", "firstName": "Caroline", "lastName": "Cooper", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Pathology Queensland and School of Medicine, University of Queensland, St Lucia, QLD, 4006, Australia."}}}, {"fullName": "Nair R", "firstName": "Radhika", "lastName": "Nair", "initials": "R", "authorId": {"@type": "ORCID", "#text": "0000-0002-6585-3384"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Rajiv Gandhi Centre for Biotechnology, Thycaud Post, Poojappura, Thiruvananthapuram, Kerala, 695014, India."}}}, {"fullName": "Herrmann D", "firstName": "David", "lastName": "Herrmann", "initials": "D", "authorId": {"@type": "ORCID", "#text": "0000-0002-9514-7501"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "McFarland A", "firstName": "Andrea", "lastName": "McFarland", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Deng N", "firstName": "Niantao", "lastName": "Deng", "initials": "N", "authorId": {"@type": "ORCID", "#text": "0000-0001-9717-2236"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Ruiz-Borrego M", "firstName": "Manuel", "lastName": "Ruiz-Borrego", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medical Oncology, Hospital Universitario Virgen del Roc\u00edo, 41013, Sevilla, Spain."}}}, {"fullName": "Rojo F", "firstName": "Federico", "lastName": "Rojo", "initials": "F", "authorId": {"@type": "ORCID", "#text": "0000-0001-9989-0290"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pathology, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040, Madrid, Spain."}}}, {"fullName": "Trigo JM", "firstName": "Jos\u00e9 M", "lastName": "Trigo", "initials": "JM", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medical Oncology, Hospital Cl\u00ednico Universitario Virgen de la Victoria, IBIMA, 29010, M\u00e1laga, Spain."}}}, {"fullName": "Bezares S", "firstName": "Susana", "lastName": "Bezares", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "GEICAM, Spanish Breast Cancer Group, Madrid, 28703, Spain."}}}, {"fullName": "Caballero R", "firstName": "Rosal\u00eda", "lastName": "Caballero", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "GEICAM, Spanish Breast Cancer Group, Madrid, 28703, Spain."}}}, {"fullName": "Lim E", "firstName": "Elgene", "lastName": "Lim", "initials": "E", "authorId": {"@type": "ORCID", "#text": "0000-0001-8065-8838"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Hospital, 2010, Darlinghurst, NSW, Australia."}]}}, {"fullName": "Timpson P", "firstName": "Paul", "lastName": "Timpson", "initials": "P", "authorId": {"@type": "ORCID", "#text": "0000-0002-5514-7080"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "O'Toole S", "firstName": "Sandra", "lastName": "O'Toole", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia."}]}}, {"fullName": "Watkins DN", "firstName": "D Neil", "lastName": "Watkins", "initials": "DN", "authorId": {"@type": "ORCID", "#text": "0000-0001-8218-4920"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Hospital, 2010, Darlinghurst, NSW, Australia."}]}}, {"fullName": "Cox TR", "firstName": "Thomas R", "lastName": "Cox", "initials": "TR", "authorId": {"@type": "ORCID", "#text": "0000-0001-9294-1745"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia."}]}}, {"fullName": "Samuel MS", "firstName": "Michael S", "lastName": "Samuel", "initials": "MS", "authorId": {"@type": "ORCID", "#text": "0000-0001-7880-6379"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, 5000, Australia."}, {"affiliation": "Faculty of Health Sciences, School of Medicine, University of Adelaide, Adelaide, SA, 5000, Australia."}]}}, {"fullName": "Mart\u00edn M", "firstName": "Miguel", "lastName": "Mart\u00edn", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Medical Oncology, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Universidad Complutense, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Oncolog\u00eda, CIBERONC-ISCIII, 28040, Madrid, Spain."}}}, {"fullName": "Swarbrick A", "firstName": "Alexander", "lastName": "Swarbrick", "initials": "A", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia. a.swarbrick@garvan.org.au."}, {"affiliation": "The Kinghorn Cancer Centre, Darlinghurst, NSW, 2010, Australia. a.swarbrick@garvan.org.au."}, {"affiliation": "St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, 2010, Australia. a.swarbrick@garvan.org.au."}]}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-7075-8448"}, {"@type": "ORCID", "#text": "0000-0001-7328-4233"}, {"@type": "ORCID", "#text": "0000-0001-7880-6379"}, {"@type": "ORCID", "#text": "0000-0001-8065-8838"}, {"@type": "ORCID", "#text": "0000-0001-8218-4920"}, {"@type": "ORCID", "#text": "0000-0001-9294-1745"}, {"@type": "ORCID", "#text": "0000-0001-9717-2236"}, {"@type": "ORCID", "#text": "0000-0001-9989-0290"}, {"@type": "ORCID", "#text": "0000-0002-5514-7080"}, {"@type": "ORCID", "#text": "0000-0002-6153-0449"}, {"@type": "ORCID", "#text": "0000-0002-6585-3384"}, {"@type": "ORCID", "#text": "0000-0002-9514-7501"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "1", "volume": "9", "journalIssueId": "2702000", "dateOfPublication": "2018 Jul", "monthOfPublication": "7", "yearOfPublication": "2018", "printPublicationDate": "2018-07-01", "journal": {"title": "Nature communications", "ISOAbbreviation": "Nat Commun", "medlineAbbreviation": "Nat Commun", "NLMid": "101528555", "ISSN": "2041-1723", "ESSN": "2041-1723"}}, "pubYear": "2018", "pageInfo": "2897", "abstractText": "The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies. In mouse models of triple\u00a0negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen. Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden. In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response. These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC.", "affiliation": "Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "research-article", "Clinical Trial, Phase I", "Journal Article"]}, "grantsList": {"grant": [{"grantId": "IN-17-070", "agency": "National Breast Cancer Foundation", "orderIn": "0"}, {"grantId": "PRAC-16-006", "agency": "National Breast Cancer Foundation", "orderIn": "0"}, {"grantId": "IIRS-18-129", "agency": "National Breast Cancer Foundation", "orderIn": "0"}, {"grantId": "EC-17-002", "agency": "National Breast Cancer Foundation", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Cell Line, Tumor"}, {"majorTopic_YN": "N", "descriptorName": "Animals"}, {"majorTopic_YN": "N", "descriptorName": "Mice, Inbred NOD"}, {"majorTopic_YN": "N", "descriptorName": "Mice, Knockout"}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Mice, SCID"}, {"majorTopic_YN": "N", "descriptorName": "Anilides", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Biphenyl Compounds", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Pyridines", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Antineoplastic Combined Chemotherapy Protocols", "meshQualifierList": {"meshQualifier": {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Treatment Outcome"}, {"majorTopic_YN": "N", "descriptorName": "Xenograft Model Antitumor Assays"}, {"majorTopic_YN": "N", "descriptorName": "Drug Resistance, Neoplasm", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Neoplastic Stem Cells", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Triple Negative Breast Neoplasms", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "GE", "qualifierName": "genetics", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Docetaxel", "meshQualifierList": {"meshQualifier": {"abbreviation": "AD", "qualifierName": "administration & dosage", "majorTopic_YN": "N"}}}]}, "chemicalList": {"chemical": [{"name": "Pyridines", "registryNumber": "0"}, {"name": "Biphenyl Compounds", "registryNumber": "0"}, {"name": "Anilides", "registryNumber": "0"}, {"name": "HhAntag691", "registryNumber": "0"}, {"name": "docetaxel", "registryNumber": "15H5577CQD"}, {"name": "sonidegib", "registryNumber": "0RLU3VTK5M"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1038/s41467-018-05220-6"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6057940"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6057940?pdf=render"}]}, "commentCorrectionList": {"commentCorrection": {"id": "PPR23892", "source": "PPR", "type": "Preprint in", "note": "CrossRef Pre-print loader", "orderIn": "10002"}}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "71", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": ["bioproject", "nct"]}, "dateOfCompletion": "2019-01-02", "dateOfCreation": "2018-07-26", "firstIndexDate": "2018-07-26", "fullTextReceivedDate": "2020-07-12", "dateOfRevision": "2019-12-10", "electronicPublicationDate": "2018-07-24", "firstPublicationDate": "2018-07-24"}, "htmllinks": "https://europepmc.org/articles/PMC6057940", "abstract": "The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies. In mouse models of triple\u00a0negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen. Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden. In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response. These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC.", "pdflinks": "https://europepmc.org/articles/PMC6057940?pdf=render", "journaltitle": "Nature communications", "authorinfo": ["Cazet AS", "Hui MN", "Elsworth BL", "Wu SZ", "Roden D", "Chan CL", "Skhinas JN", "Collot R", "Yang J", "Harvey K", "Johan MZ", "Cooper C", "Nair R", "Herrmann D", "McFarland A", "Deng N", "Ruiz-Borrego M", "Rojo F", "Trigo JM", "Bezares S", "Caballero R", "Lim E", "Timpson P", "O'Toole S", "Watkins DN", "Cox TR", "Samuel MS", "Mart\u00edn M", "Swarbrick A"], "title": "Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer."}